user

Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US

被引：0
|
作者：
Sundar Jagannath
Nedra Joseph
Jinghua He
Concetta Crivera
Alex Z. Fu
Ashraf Garret
Nina Shah
机构：
[1] Icahn School of Medicine at Mount Sinai,Real World Value and Evidence (Oncology)
[2] Janssen Scientific Affairs,undefined
[3] LLC,undefined
[4] Janssen Scientific Affairs,undefined
[5] LLC,undefined
[6] Georgetown University Medical Center,undefined
[7] Legend Biotech Inc.,undefined
[8] University of California San Francisco,undefined
来源：
Oncology and Therapy | 2021年 / 9卷
关键词：
Healthcare costs; Healthcare resource utilization; Multiple myeloma; Triple class exposure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：659 / 669
页数：10
相关论文
共 50 条
  • [41] Comparative effectiveness of linvoseltamab versus standard-of-care (SOC) treatment (tx) in real-world patients (pts) in the United States (US) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
    Kumar, Shaji
    Weisel, Katja C.
    Ma, Qiufei
    Hampp, Christian
    Humblet, Olivier
    Shokoohi, Mostafa
    Bonar, Nicolle
    Spin, Paul
    Harnett, James
    Ge, Wenzhen
    Jalbert, Jessica J.
    Sobel, Rachel E.
    Kroog, Glenn Scott
    Rodriguez-Lorenc, Karen
    Jagannath, Sundar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma
    Zanwar, Saurabh
    Ho, Matthew
    Kapoor, Prashant
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Dingli, David
    Kourelis, Taxiarchis
    Fonder, Amie
    Hobbs, Miriam
    Hwa, Yi
    Gonsalves, Wilson
    Warsame, Rahma
    Muchtar, Eli
    Leung, Nelson
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji
    LEUKEMIA, 2022, 36 (03) : 873 - 876
  • [43] Outcomes of triple-class refractory multiple myeloma patients at a single clinic: A retrospective study
    Danis, Ryan
    Bujarski, Sean
    Yashar, David
    Del Dosso, Ashley
    Moore, Jonathan
    Mettias, Sarah
    Berenson, James R.
    LEUKEMIA RESEARCH, 2025, 151
  • [44] Clinical Outcomes for Patients with Triple Class Exposed Relapsed and Refractory Multiple Myeloma in Alberta, Canada
    Jimenez-Zepeda, Canada Victor H.
    Cheung, Winson Y.
    Stephen, Mariet Mathew
    Chan, Henry
    BLOOD, 2024, 144 : 6975 - 6975
  • [45] Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma
    Saurabh Zanwar
    Matthew Ho
    Prashant Kapoor
    Angela Dispenzieri
    Martha Q. Lacy
    Morie A. Gertz
    Francis K. Buadi
    Suzanne R. Hayman
    David Dingli
    Taxiarchis Kourelis
    Amie Fonder
    Miriam Hobbs
    Yi Hwa
    Wilson Gonsalves
    Rahma Warsame
    Eli Muchtar
    Nelson Leung
    Robert A. Kyle
    S. Vincent Rajkumar
    Shaji Kumar
    Leukemia, 2022, 36 : 873 - 876
  • [46] Outcomes of Triple Class (Proteasome Inhibitor, IMiDs and Monoclonal Antibody) Refractory Patients with Multiple Myeloma
    Zanwar, Saurabh
    Ho, Matthew
    Kapoor, Prashant
    Dispenzieri, Angela
    Gertz, Morie A.
    Lacy, Martha Q.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Dingli, David
    Kourelis, Taxiarchis
    Fonder, Amie
    Hwa, Yi L.
    Hobbs, Miriam A.
    Gonsalves, Wilson I.
    Warsame, Rahma M.
    Muchtar, Eli
    Leung, Nelson
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji
    BLOOD, 2021, 138
  • [47] Clustering and Healthcare Costs With Multiple Chronic Conditions in a US Study
    Hajat, Cother
    Siegal, Yakir
    Adler-Waxman, Amalia
    FRONTIERS IN PUBLIC HEALTH, 2021, 8
  • [48] Evaluation of costs incurred for patients with multiple trauma particularly from the perspective of the hospital
    Schwermann, T
    Grotz, M
    Blanke, M
    Ruchholtz, S
    Lefering, R
    von der Schulenburg, JMG
    Krettek, C
    Pape, HC
    UNFALLCHIRURG, 2004, 107 (07): : 563 - +
  • [49] A Patient Perspective on Actionable Steps to Address Disparities in Healthcare Among US Patients with Multiple Myeloma
    Gilbert, Oya
    Aiello, Jack
    Omel, Jim
    Price, Pamela
    Davis, Audrey
    Ortiz-Ravick, Laura
    Gentry, Emily
    Shah, Richa
    Soussou, Elpitha
    Blue, Brandon
    BLOOD, 2024, 144 : 2383 - 2384
  • [50] Treatment Patterns and Outcomes of Patients with Double-Class Refractory or Triple-Class Refractory Multiple Myeloma: A Retrospective US Electronic Health Record Database Study
    Wang, Feng
    Gorsh, Boris
    Sarkissian, Maral Der
    Paka, Prani
    Bhak, Rachel
    Boytsov, Natalie
    Zichlin, Miriam L.
    Sansbury, Leah
    Yee, Christopher W.
    Ferrante, Shannon
    Khanal, Anamika
    Noman, Ahmed
    Duh, Mei Sheng
    BLOOD, 2021, 138
12345